Peijia MedicalPEJMF 74 3-Year ROIIC % is 42.86 as of Dec. 2025. GuruFocus rates PEJMF with a GF Score™ of 74/100 and a GF Value™ of $2.72. The stock has 4 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Peijia Medical ranks better than 81.05% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Peijia Medical's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 42.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Peijia Medical's 3-Year ROIIC % or its related term are showing as below:
PEJMF's 3-Year ROIIC % is ranked better than 81.05% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs PEJMF: 42.86
Peijia Medical (OTCPK:PEJMF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Peijia Medical 3-Year ROIIC % Related Terms
Peijia Medical 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Peijia Medical's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Peijia Medical's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peijia Medical 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Peijia Medical's 3-Year ROIIC % falls into.
Peijia Medical's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -27.73 (Dec. 2025) - -79.138 (Dec. 2022) )
/
( 316.382 (Dec. 2025) - 196.219 (Dec. 2022) )
=
51.408
/
120.163
=
42.78%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Peijia Medical (PEJMF) has a 3-Year ROIIC % of 42.86 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Peijia Medical and its competitors. According to the industry distribution chart, Peijia Medical ranks #151 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 18.9%.
Is Peijia Medical's 3-Year ROIIC % too high?
Peijia Medical's current 3-Year ROIIC % is 42.86. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Peijia Medical's value of 42.86 is 2815.6% above this industry median. Based on the distribution chart, Peijia Medical ranks #151 out of 797 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Peijia Medical has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Peijia Medical ranks #151 out of 797 companies for 3-Year ROIIC %. This places Peijia Medical in the top 19% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.47. Peijia Medical's value of 42.86 is 2815.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peijia Medical's current 3-Year ROIIC % of 42.86 is 2815.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Peijia Medical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peijia Medical's current 3-Year ROIIC % is 42.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current 3-Year ROIIC % of 42.86. The stock's GF Value™ is $2.72, compared to a current price of $1.39 — trading 49% below its estimated fair value. The current 3-Year ROIIC % is 42.86 and 2815.6% above the Medical Devices & Instruments industry median of 1.47. Peijia Medical's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current 3-Year ROIIC % is 42.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peijia Medical (PEJMF) Overvalued in 2026?
Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued.
The current stock price of $1.39 is trading 49% below its estimated GF Value™ of $2.72.
Key valuation signals for PEJMF:
3-Year ROIIC %: 42.86
GF Value™: $2.72 vs. price of $1.39 (49% below fair value)
Industry Position: 2815.6% above the Medical Devices & Instruments median (#151 of 797)
No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
74GF Score
Get the complete analysis for PEJMF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PEJMF has been successfully added to your 
